Dalbavancin

5 trials 3 recruiting JAnti-infectives

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

1 Completed trials

5 Sponsors

4 Countries

Phase III

Phase II/III

Phase IV

Phase III: 1 Phase II/III: 1 Phase IV: 3

Indications tested

Endocarditis enterococcal 1 Staphylococcal infection 1 Implant site infection 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire De Nantes 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH 1 Region Midtjylland 1

All trials

5 total

Pilot Study - Safety and Efficacy of Dalbavancin in Early Outpatient Treatment of Erysipelas and Limited Cellulitis Pending

2025-524877-18-00 Phase IV 1 country Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Phase IV 1 country Region Midtjylland
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Efficacy of dalbavancin in osteoarticular infections associated with hip, knee and shoulder prostheses PRO-DALBA Ended

2024-518183-12-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice

Showing 1–5 of 5 trials

← All drugs A–Z